There are divergent positions in the scientific and regulatory communities regarding whether modifications to EPA’s standard guidelines for reproductive and developmental toxicity testing and risk assessment are needed in order to detect and characterize low-dose adverse effects of endocrine disrupting chemicals (EDCs).

• EPA’s Nonmonotonic Dose Response Curve Workplan (PDF)(3 pp, 116 K)